Troglitazone
Chemical compound / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Troglitazone?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Troglitazone is an antidiabetic and anti-inflammatory drug, and a member of the drug class of the thiazolidinediones. It was prescribed for people with diabetes mellitus type 2.[1]
Quick Facts Clinical data, Trade names ...
Clinical data | |
---|---|
Trade names | Rezulin, Resulin, Romozin, Noscal |
Routes of administration | By mouth (tablets) |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Elimination half-life | 16–34 hours |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank |
|
ChemSpider |
|
UNII | |
KEGG |
|
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C24H27NO5S |
Molar mass | 441.54 g·mol−1 |
3D model (JSmol) | |
Melting point | 184 to 186 °C (363 to 367 °F) |
| |
| |
NY (what is this?) (verify) |
Close
It was patented in 1983 and approved for medical use in 1997.[2] It was subsequently withdrawn.